On April 15, 2025, the Annual General Meeting of Shareholders of DMC Pharmaceutical Company took place successfully at the company headquarters. The meeting was chaired by Mr. Nguyen Van A, Chairman of the Board. Shareholders unanimously approved the financial reports for 2024, assessing business operations, highlighting achievements and challenges faced. The Board presented the development plan for 2025, aiming for revenue growth and market expansion. Shareholders also elected two new members to the Board and approved new regulations regarding shareholder rights. The resolution was passed with a majority vote, and the minutes of the meeting were signed and publicly announced according to legal requirements. This event marks a significant step in strengthening the relationship between the company and its shareholders, creating momentum for future plans.
Leave a Reply